معرفی
Darja Sadovska is a researcher at Rīga Stradiņš University with expertise in mycobacterial genomics, antimicrobial resistance, and tuberculosis treatment. Her work contributes to UN Sustainable Development Goal 3 (Good Health and Well-being), particularly addressing tuberculosis control strategies and personalized therapy approaches. She has conducted research funded by the Latvian Council of Science, focusing on projects like 'New knowledge and approaches to reduce antimicrobial resistance' and 'Tuberculosis treatment: exploring perspectives for personalized therapy.'
Education:
- Doctoral Thesis (2025): Application of Mycobacterium tuberculosis whole-genome sequencing to improve tuberculosis control strategies at Rīga Stradiņš University.
Research Interests: Her research emphasizes the application of whole-genome sequencing to study drug resistance mechanisms in Mycobacterium tuberculosis, genetic polymorphisms affecting tuberculosis treatment, and epidemiological tracing of tuberculosis outbreaks. She collaborates on projects addressing antimicrobial resistance, HIV vaccination coverage, and personalized medicine approaches for tuberculosis patients.
Advising & Grants:
- Co-investigator in two Latvian Council of Science-funded projects (2021-2025).
- Guided research on pharmacogenomics, drug susceptibility testing, and molecular epidemiology.
Labs/Teams: Participates in multidisciplinary teams focused on tuberculosis research, antimicrobial resistance, and infectious disease genomics at Rīga Stradiņš University and collaborating institutions.
